| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Plant Your Money in the Foreign Soil |
|
Top Articles - Plant Your Money in the Foreign Soil
Are you one of those who are forever on a hunt for quick tips on investment? If so, then it is very likely According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product that the term offshore investment has been tossed at you more often than not. What is offshore invest ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ment? Offshore investment is a way of making one's money grow by investing in various ventures abroad that is lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. outside your own country of residence. Why venture into offshore investment? The most popular reason cited f here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe r investing in foreign waters is to evade the tax enforcements in one's own country. Most people who reside i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n high-tax areas like US, UK, Canada or Japan see domestic investments as a futile exercise because of the hea ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc vy tax penalties that one has to pay. While tax is the driving force behind majority of offshore investments, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi there are others who invest into foreign lands with the intention of earning huge returns and not of evadi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ng taxes. A survey by YouGov revealed that as much as 55% of adult Britons were seriously considering settling i and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n another country. Two factors can be attributed to have triggered this feeling among Britons. The first being, t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e ever worsening pension situation in the country, which has prompted several Britons to look elsewhere fo ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a r their retirement savings. The second of course being the universal dream of owning a holiday home in an exotic dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod country. What options are available under offshore investment? United Nations Conference on Trade and Developmen cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t or UNCTAD reveals that foreign investments have seen a recent shift towards services in all regions of t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e world. Besides the most popular overseas call centres, other services including water, electricity and busin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ess services have also started seeing a lot of money being poured into them. Besides these, property has alw ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ays been a hot market for investments. As a potential investor you can also look into more traditional opt y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ons like funds and savings plan. Beware Investor! No matter what your reason is behind investing or what scheme . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de you are putting your money into, the catch phrase always is Caveat emptor! Or beware! As an investor you are sole elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ly responsible for your investment and so before taking the plunge you must assess your own risk tolerance tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Foreign Money Exchange Service (Forex) Some Tips to Help You Avoid Debt
|